Incorporating ACR Guideline Concepts for Rheumatoid Arthritis into Clinical Care

Title:

Incorporating ACR Guideline Concepts for Rheumatoid Arthritis into Clinical Care

Topic: Rheumatology
Relevant Terms: Chronic Pain, Pain Management
Primary Audience: Rheumatologists, Rheumatology Nurses
Launch Date: 26-Feb-13
Credits: 0.75 AMA PRA Category 1 Credit
0.75 ANCC contact hour
1 CA-BRN contact hour
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Managing a Non-Responder to Methotrexate

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Implement evidence-based guidelines into practice as warranted for the treatment of specific subsets of patients with rheumatoid arthritis (RA)
  2. Compare the safety profiles of current biologic DMARDs commonly used for the treatment of RA 

    Faculty

    Kenneth G. Saag MD, MSc
    Professor of Medicine, Division of Clinical Immunology and Rheumatology
    University of Alabama at Birmingham (UAB) School of Medicine
    Birmingham, Alabama
    Vibeke Strand, MD
    Clinical Professor, Adjunct
    Division of Immunology/Rheumatology
    Stanford University School of Medicine
    Biopharmaceutical Consultant 
    Stanford, California
    Jacqueline Fritz, RN, MSN, CNS
    Medical Advancement Center
    Critical Care and Rheumatology Specialist
    Cypress, California
    Instructions on How to Receive Credit
    • Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information. 
    • Complete the entire activity, pre/post-test and evaluation. 
    • After passing the post-test, print out your electronic CE certificate. 
    • In order to successfully complete this activity learners must achieve a minimum of 70% on the post-test.

    This activity is supported by unrestricted educational grants from Genentech, Inc., UCB, AbbVie, Inc., & Amgen.

    This activity is sponsored by the Institute for Continuing Healthcare Education

    Release Date: February 26, 2013
    Expiration Date: February 26, 2014
     
    Accreditation Statements
    Physicians
    The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The Institute for Continuing Healthcare Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Nurses
    The Institute for Continuing Healthcare Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    This activity offers 0.75 contact hours to participating nurses. This credit may be applied toward licensure requirements in those states that recognize American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA) accredited providers.

    Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA. 

    California Nurses
    The Institute for Continuing Healthcare Education is approved by the California Board of Registered Nursing, Provider Number 13313. The Institute for Continuing Healthcare Education approves this activity for 1.0 contact hours.
     
    Disclosure
    Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.

    Faculty
    Kenneth G Saag, MD, MSc, has disclosed the following relevant financial relationships that have occurred within the past 12 months: ACR/G; Ardea, Regeneron, takeda & Savient/C, G, & H.

    Vibeke Strand, MDhas disclosed the following relevant financial relationships that have occurred within the past 12 months: BMS/ A; Abbott, Amgen, Genentech, Pfizer & UCB/A, C and others.

    Jacqueline Fritz, RN, MSN, CNS, has disclosed the following relevant financial relationships that have occurred within the past 12 months: UCB, Novartis, Genentech, Amgen, Pfizer, Savient/SB.

    Medical Writer
    Anne Jacobson, MPH, CCMEP, Medical Writer, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

    Peer Reviewer
    Stanford Peng, MD
    , has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of this activity.

    Activity Development and Management Team
    Cathy Pagano, CCMEPAllison A. Muller, Pharm.D, D.ABAT;  Scott Kober, CCMEPApril Reynolds, MS, ELSSandra Davidson; and Tina Chiu, MEd are employees of the Institute and have no relationships to disclose.
     
    Off-label Product Disclosure
    This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
     
    COURSE VIEWING REQUIREMENTS
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac
     
    For additional technical support, please send an email to tchiu@iche.edu. 

    General Disclosure and Copyright Statement
    The opinions expressed in this publication are those of the participating faculty and not those of the Institute for Continuing Healthcare Education (the Institute), Genentech, Inc., UCB, or any manufacturers of products mentioned herein.

    This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.

    Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.

    Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.
     
    The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.